We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Company Warned for Noncompliance on Clinical Trial Protocol, Protections
Company Warned for Noncompliance on Clinical Trial Protocol, Protections
September 28, 2012
The FDA handed Atlanta-based CardioMEMS a warning letter for numerous deviations related to a clinical investigation and PMA for its CardioMEMS HF Pressure Measurement System.